Most Recent

image: Roadmap to an HIV Vaccine

Roadmap to an HIV Vaccine

By | April 3, 2013

Researchers track the evolution of HIV in a single patient to understand what drives the production of broadly neutralizing antibodies.

0 Comments

image: Novartis Linked to Retracted Papers?

Novartis Linked to Retracted Papers?

By | April 2, 2013

A Japanese newspaper claims that the pharma giant funded flawed research that revealed extra health benefits for one of its top-selling drugs.

0 Comments

image: Branching Out

Branching Out

By | April 1, 2013

Satellites of the Golgi apparatus generate the microtubules used to grow outer dendrite branches in Drosophila neurons.

0 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Contributors

Contributors

By | April 1, 2013

Meet some of the people featured in the April 2013 issue of The Scientist.

0 Comments

image: Making Cancer More Transparent

Making Cancer More Transparent

By | April 1, 2013

A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.

3 Comments

image: Pluripotent Until Needed

Pluripotent Until Needed

By | April 1, 2013

Microarrays help keep induced pluripotent stem cell lines in check, from start to finish.

0 Comments

image: Smurf-y Old Age

Smurf-y Old Age

By | April 1, 2013

Flies turning blue help researchers link the deterioration of the intestinal barrier to age-related death.

0 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2013

April 2013's selection of notable quotes

0 Comments

image: Up, Up, and Array

Up, Up, and Array

By | April 1, 2013

By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech